Cadent Therapeutics: CAD-9303 for Schizophrenia gets IND Application Clearance, Initiating Dosing of Subjects – CBI
Homepage /  Press Release /  Cadent Therapeutics: CAD-9303 for Schizophrenia gets IND Application Clearance, Initiating Dosing of Subjects

Press Release

Cadent Therapeutics: CAD-9303 for Schizophrenia gets IND Application Clearance, Initiating Dosing of Subjects